Submitted:
30 October 2025
Posted:
03 November 2025
You are already at the latest version
Abstract
Background/Objectives: Blood donation is essential for health systems and serves as a valuable epidemiological model for examining physiological adaptation to controlled blood loss. Regular donors constitute a distinct, health-screened population whose biological responses provide insight into resilience mechanisms and determinants of population health. Hypoxia-inducible factor 1-alpha (HIF-1α) is a key regulator of erythropoiesis and cellular response to hypoxia, and its modulation following blood donation may inform donor safety and the sustainability of donation programs. This study aimed to characterize the sociodemographic, lifestyle, and anthropometric profiles of blood donors in relation to hematopoietic biomarkers (vitamin B₁₂ and folic acid) and to evaluate changes in serum HIF-1α concentration after donation, emphasizing the public health relevance of voluntary blood donation as a model for healthy and socially engaged populations. Methods: A cross-sectional study was conducted among 324 voluntary blood donors (159 regular and 165 occasional). Serum HIF-1α was measured before and 30 minutes after donation, together with vitamin B₁₂ and folic acid levels. Sociodemographic and lifestyle characteristics (physical activity, smoking, dietary habits) were collected through standardized questionnaires (EHIS-3, FFQ), and anthropometric parameters were assessed. Results: Regular donors were older and predominantly male, with comparable socioeconomic indicators between groups. Both regular and occasional donors showed favorable lifestyle profiles, including low smoking prevalence and moderate physical activity. Skinfold thickness was significantly greater in regular donors (p<0.001). No significant associations were found between lifestyle factors and vitamin B₁₂ or folate levels. The main biological finding was a robust post-donation increase in HIF-1α concentrations (≈80%, p<0.001), independent of donation frequency or lifestyle. Conclusions: Blood donation induces a rapid elevation in HIF-1α, reflecting activation of hypoxia-responsive pathways and short-term hematopoietic adaptation. Beyond its biomedical relevance, voluntary blood donation represents a meaningful epidemiological and public health model for studying physiological resilience and the health benefits of altruistic behavior. These findings underscore the importance of donor surveillance and motivation as components of broader preventive health and health equity strategies.
Keywords:
1. Introduction
2. Participants and Methods
2.1. Participants
2.2. Study Design
2.3. Questionnaires
2.3.1. Sociodemographic Questionnaire
2.3.2. European Health Interview Survey (EHIS)
2.3.3. Food Frequency Questionnaire (FFQ)
2.4. Laboratory Analysis
2.5. Statistical Analyses
2.6. Ethical Considerations
3. Results
3.1. Socio-Demographic Characteristics
3.2. Blood Donation Characteristics
3.3. Nutritional and Life-Style Habits
3.4. Serum Hypoxia Inducible Factor 1 Concentrations
3.5. Serum Levels of Folate and Vitamin B12
4. Discussion
Study Limitations
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Hughes, S.D.; France, C.L.; West-Mitchell, K.A.; Pina, T.; McElfresh, D.; Sayers, M.; Bryant, B.J. NHLBI SoS Working Group #1: Blood Donors and the Supply. Advancing Understandings of Blood Donation Motivation and Behavior. Transfus. Med. Rev. 2023, 37, 150780. [Google Scholar] [CrossRef] [PubMed]
- Goodnough, L.T.; Brecher, M.E.; Kanter, M.H.; AuBuchon, J.P. Transfusion medicine. First of two parts—blood transfusion. N. Engl. J. Med. 1999, 340, 438–447. [Google Scholar] [CrossRef] [PubMed]
- Raval, J.S.; Griggs, J.R.; Fleg, A. Blood Product Transfusion in Adults: Indications, Adverse Reactions, and Modifications. Am. Fam. Physician. 2020, 102, 30–38. [Google Scholar] [PubMed]
- Cap, A.P.; Beckett, A.; Benov, A.; Borgman, M.; Chen, J.; Corley, J.B.; Doughty, H.; Fisher, A.; Glassberg, E.; Gonzales, R.; et al. Whole Blood Transfusion. Mil. Med. 2018, 183, 44–51. [Google Scholar] [CrossRef] [PubMed]
- Miller, A. Blood Donation and Public Health—The Broader Impact on Communities. Donate Blood–The Blood Connection. Available online: https://thebloodconnection.org/blood-donation-and-public-health-the-broader-impact-on-communities/ (accessed on 1 October 2024).
- McQuilten, Z.K.; Crighton, G.; Brunskill, S.; Morison, J.K.; Richter, T.H.; Waters, N.; Murphy, M.F.; Wood, E.M. Optimal Dose, Timing and Ratio of Blood Products in Massive Transfusion: Results from a Systematic Review. Transfus. Med. Rev. 2018, 32, 6–15. [Google Scholar] [CrossRef] [PubMed]
- Ngatuvai, M.; Zagales, I.; Sauder, M.; Andrade, R.; Santos, R.G.; Bilski, T.; Kornblith, L.; Elkbuli, A. Outcomes of Transfusion With Whole Blood, Component Therapy, or Both in Adult Civilian Trauma Patients: A Systematic Review and Meta-Analysis. J. Surg. Res. 2023, 287, 193–201. [Google Scholar] [CrossRef] [PubMed]
- Shah, A.; Klein, A.A.; Agarwal, S.; Lindley, A.; Ahmed, A.; Dowling, K.; Jackson, E.; Das, S.; Raviraj, D.; Collis, R.; et al. Association of Anaesthetists guidelines: The Use of Blood Components and Their Alternatives. Anaesthesia 2025, 80, 425–447. [Google Scholar] [CrossRef] [PubMed]
- Jacobs, J.W.; Booth, G.S.; Lewis-Newby, M.; Saifee, N.H.; Ferguson, E.; Cohn, C.S.; Delaney, M.; Morley, S.; Thomas, S.; Thorpe, R.; et al. Medical, Societal, and Ethical Considerations for Directed Blood Donation in 2025. Ann. Intern. Med. 2025, 178, 1021–1026. [Google Scholar] [CrossRef] [PubMed]
- Jacobs, J.W.; Bates, I.; Cohn, C.S.; Choudhury, N.; Owusu-Ofori, S.; Vrielink, H.; Patel, E.U.; Wendel, S.; Tobian, A.A.R.; Bloch, E.M. The Global Blood Donation Index: An Imperfect Measure of Transfusion Need. Lancet 2024, 404, 988–990. [Google Scholar] [CrossRef] [PubMed]
- Jacobs, J.W.; Bates, I.; M’baya, B.; Eichbaum, Q.; Louw, V.J.; Al-Riyami, A.Z.; Tayou, C.; Wendel, S.; Tobian, A.A.R.; Bloch, E.M. Ensuring a Safe and Sufficient Global Blood Supply. N. Engl. J. Med. 2024, 391, 1079–1081. [Google Scholar] [CrossRef] [PubMed]
- Gasparovic Babic, S.; Krsek, A.; Baticic, L. Voluntary Blood Donation in Modern Healthcare: Trends, Challenges, and Opportunities. Epidemiologia 2024, 5, 770–784. [Google Scholar] [CrossRef] [PubMed]
- Mousavi, S.A.; Hermundstad, B.; Saether, P.C.; Nybruket, M.J.; Knutsen, T.R.; Llohn, A.H. Health Behavior and Lifestyle Trends among Platelet Donors: Results from a Questionnaire-Based Survey in Norway. Biomed. Res. Int. 2021, 2021, 8891885. [Google Scholar] [CrossRef] [PubMed]
- Chassé, M.; McIntyre, L.; English, S.W.; Tinmouth, A.; Knoll, G.; Wolfe, D.; Wilson, K.; Shehata, N.; Forster, A.; van Walraven, C.; et al. Effect of Blood Donor Characteristics on Transfusion Outcomes: A Systematic Review and Meta-Analysis. Transfus. Med. Rev. 2016, 30, 69–80. [Google Scholar] [CrossRef] [PubMed]
- Chassé, M.; English, S.W.; McIntyre, L.; Knoll, G.; Shehata, N.; Forster, A.; Wilson, K.; van Walraven, C.; Tinmouth, A.; Fergusson, D.A. Effect of Blood Donor Characteristics on Transfusion Outcomes: A Protocol for Systematic Review and Meta-Analysis. Syst. Rev. 2014, 3, 28. [Google Scholar] [CrossRef] [PubMed]
- Gebreyes, D.S.; Kifetew, K.; Gizaw, A.; Abebe, T.A.; Shenkutie, T.T.; Genetu, D.; Yitayew, B.; Hailu, A. Prevalence and Risk Factors of Transfusion-Transmissible Infections among Voluntary Blood Donors in North Shoa, Amhara Region, Ethiopia: A Cross-Sectional Study. Health Sci. Rep. 2025, 8, e70769. [Google Scholar] [CrossRef] [PubMed]
- Sosa-Jurado, F.; Palencia-Lara, R.; Xicoténcatl-Grijalva, C.; Bernal-Soto, M.; Montiel-Jarquin, Á.; Ibarra-Pichardo, Y.; Rosas-Murrieta, N.H.; Lira, R.; Cortes-Hernandez, P.; Santos-López, G. Donated Blood Screening for HIV, HCV and HBV by ID-NAT and the Residual Risk of Iatrogenic Transmission in a Tertiary Care Hospital Blood Bank in Puebla, Mexico. Viruses 2023, 15, 1331. [Google Scholar] [CrossRef] [PubMed]
- Schreiber, G.B.; Busch, M.P.; Kleinman, S.H.; Korelitz, J.J. The Risk of Transfusion-Transmitted Viral Infections. The Retrovirus Epidemiology Donor Study. N. Engl. J. Med. 1996, 334, 1685–1690. [Google Scholar] [CrossRef] [PubMed]
- Seifried, E.; Roth, W.K. Optimal Blood Donation Screening Annotation. Br. J. Haematol. 2000, 109, 694–698. [Google Scholar] [CrossRef] [PubMed]
- Li, L.; Li, K.Y.; Yan, K.; Ou, G.; Li, W.; Wang, J.; Song, N.; Tian, L.; Ji, X.; Chen, Y.; et al. The History and Challenges of Blood Donor Screening in China. Transfus. Med. Rev. 2017, 31, 89–93. [Google Scholar] [CrossRef] [PubMed]
- Veca, S. Blood Donation and the Policies of Solidarity. Transfus. Apher. Sci. 2013, 49, 415–420. [Google Scholar] [CrossRef] [PubMed]
- Orkin, S.H. Hematopoiesis: How Does It Happen? Curr. Opin. Cell Biol. 1995, 6, 870–877. [Google Scholar] [CrossRef] [PubMed]
- Balamurugan, K. HIF-1 at the Crossroads of Hypoxia, Inflammation, and Cancer. Int. J. Cancer 2016, 138, 1058–1066. [Google Scholar] [CrossRef] [PubMed]
- Iommarini, L.; Porcelli, A.M.; Gasparre, G.; Kurelac, I. Non-Canonical Mechanisms Regulating Hypoxia-Inducible Factor 1 Alpha in Cancer. Front. Oncol. 2017, 7, 286. [Google Scholar] [CrossRef] [PubMed]
- Zhao, Y.; Xing, C.; Deng, Y.; Ye, C.; Peng, H. HIF-1α Signaling: Essential Roles in Tumorigenesis and Implications in Targeted Therapies. Genes Dis. 2023, 11, 234–251. [Google Scholar] [CrossRef] [PubMed]
- Kim, J.W.; Tchernyshyov, I.; Semenza, G.L.; Dang, C.V. HIF-1-Mediated Expression of Pyruvate Dehydrogenase Kinase: A Metabolic Switch Required for Cellular Adaptation to Hypoxia. Cell Metab. 2006, 3, 177–185. [Google Scholar] [CrossRef] [PubMed]
- Dara, R.C.; Marwaha, N.; Khetan, D.; Patidar, G.K. A Randomized Control Study to Evaluate Effects of Short-Term Oral Iron Supplementation in Regular Voluntary Blood Donors. Indian J. Hematol. Blood Transfus. 2016, 32, 299–306. [Google Scholar] [CrossRef] [PubMed]
- Chaudhary, M.R.; Chaudhary, S.; Sharma, Y.; Singh, T.A.; Mishra, A.K.; Sharma, S.; Mehdi, M.M. Aging, Oxidative Stress and Degenerative Diseases: Mechanisms, Complications and Emerging Therapeutic Strategies. Biogerontology 2023, 24, 609–662. [Google Scholar] [CrossRef] [PubMed]
- Ruggeri, R.M.; Giovinazzo, S.; Barbalace, M.C.; Cristani, M.; Alibrandi, A.; Vicchio, T.M.; Giuffrida, G.; Aguennouz, M.H.; Malaguti, M.; Angeloni, C.; et al. Influence of Dietary Habits on Oxidative Stress Markers in Hashimoto’s Thyroiditis. Thyroid 2021, 31, 96–105. [Google Scholar] [CrossRef] [PubMed]
- Dorle, A.; Gajbe, U.; Singh, B.R.; Noman, O.; Dawande, P. A Review of Amelioration of Awareness About Blood Donation Through Various Effective and Practical Strategies. Cureus 2023, 15, e46892. [Google Scholar] [CrossRef] [PubMed]
- Misje, A.H.; Bosnes, V.; Gåsdal, O.; Heier, H.E. Motivation, Recruitment and Retention of Voluntary Non-Remunerated Blood Donors: A Survey-Based Questionnaire Study. Vox Sang. 2005, 89, 236–244. [Google Scholar] [CrossRef] [PubMed]
- Hintzpeter, B.; Finger, J.D.; Allen, J.; Kuhnert, R.; Seeling, S.; Thelen, J.; Lange, C. European Health Interview Survey (EHIS) 2—Background and Study Methodology. J. Health Monit. 2019, 4, 66–79. [Google Scholar] [CrossRef] [PubMed]
- Statistical Office of the European Union (Eurostat). European Health Interview Survey (EHIS Wave 2) – Methodological Manual; Publications Office of the European Union: Luxembourg, 2013; Available online: https://ec.europa.eu/eurostat/web/products-manuals-and-guidelines/-/KS-RA-13-018 (accessed on 12 September 2024).
- European Commission. Commission Regulation (EU) No 141/2013 of 19 February 2013 Implementing Regulation (EC) No 1338/2008 of the European Parliament and of the Council on Community Statistics on Public Health and Health and Safety at Work, as Regards Statistics Based on the European Health Interview Survey (EHIS). Off. J. Eur. Union 2013, L47, 20–29.
- European Commission. Commission Regulation (EU) No 68/2014 of 27 January 2014 Amending Regulation (EU) No 141/2013 Implementing Regulation (EC) No 1338/2008 of the European Parliament and of the Council on Community Statistics on Public Health and Health and Safety at Work, as Regards Statistics Based on the European Health Interview Survey (EHIS) by Reason of the Accession of Croatia to the European Union. Off. J. Eur. Union 2014, L23, 9–13.
- Colić Barić, I.; Satalić, Z.; Keser, I.; Cecić, I.; Sucić, M. Validation of the Folate Food Frequency Questionnaire with Serum and Erythrocyte Folate and Plasma Homocysteine. Int. J. Food Sci. Nutr. 2009, 60, 10–18. [Google Scholar] [CrossRef]
- Colić Barić, I.; Satalić, Z.; Pedisić, Z.; Zizić, V.; Linarić, I. Validation of the Folate Food Frequency Questionnaire in Vegetarians. Int. J. Food Sci. Nutr. 2009, 60, 88–95. [Google Scholar] [CrossRef]
- Močić Pavić, A.; Sila, S.; Niseteo, T.; Hojsak, I.; Kolaček, S. Development and Validation of a Food Frequency Questionnaire for Population of Adolescents in Croatia. Food Technol. Biotechnol. 2021, 59, 49–58. [Google Scholar] [CrossRef]
- Rabić, D.; Sindik, J.; Missoni, S. Development and Validation of a Self-Administered Food Frequency Questionnaire to Assess Habitual Dietary Intake and Quality of Diet in Healthy Adults in the Republic of Croatia. Coll. Antropol. 2014, 38, 1017–1026. [Google Scholar]
- Abolghasemi, H.; Hosseini-Divkalayi, N.S.; Seighali, F. Blood Donor Incentives: A Step Forward or Backward. Asian J. Transfus. Sci. 2010, 4, 9–13. [Google Scholar] [CrossRef] [PubMed]
- Marantidou, O.; Loukopoulou, L.; Zervou, E.; Martinis, G.; Egglezou, A.; Fountouli, P.; Dimoxenous, P.; Parara, M.; Gavalaki, M.; Maniatis, A. Factors That Motivate and Hinder Blood Donation in Greece. Transfus. Med. 2007, 17, 443–450. [Google Scholar] [CrossRef] [PubMed]
- Misje, A.H.; Bosnes, V.; Heier, H.E. Gender Differences in Presentation Rates, Deferrals and Return Behaviour among Norwegian Blood Donors. Vox Sang. 2010, 98, e241–e248. [Google Scholar] [CrossRef] [PubMed]
- Glynn, S.A.; Williams, A.E.; Nass, C.C.; Bethel, J.; Kessler, D.; Scott, E.P.; Fridey, J.; Kleinman, S.H.; Schreiber, G.B.; Retrovirus Epidemiology Donor Study. Attitudes Toward Blood Donation Incentives in the United States: Implications for Donor Recruitment. Transfusion 2003, 43, 7–16. [Google Scholar] [CrossRef] [PubMed]
- Veldhuizen, I.J.; Doggen, C.J.; Atsma, F.; De Kort, W.L. Donor Profiles: Demographic Factors and Their Influence on the Donor Career. Vox Sang. 2009, 97, 129–138. [Google Scholar] [CrossRef] [PubMed]
- Timmer, T.C.; de Groot, R.; Habets, K.; Merz, E.M.; Prinsze, F.J.; Atsma, F.; de Kort, W.L.A.M.; van den Hurk, K. Donor InSight: Characteristics and Representativeness of a Dutch Cohort Study on Blood and Plasma Donors. Vox Sang. 2019, 114, 117–128. [Google Scholar] [CrossRef] [PubMed]
- Rigas, A.S.; Sørensen, C.J.; Pedersen, O.B.; Petersen, M.S.; Thørner, L.W.; Kotzé, S.; Sørensen, E.; Magnussen, K.; Rostgaard, K.; Erikstrup, C.; et al. Predictors of Iron Levels in 14,737 Danish Blood Donors: Results from the Danish Blood Donor Study. Transfusion 2014, 54, 789–796. [Google Scholar] [CrossRef] [PubMed]
- Hoier, B.; Hellsten, Y. Exercise-Induced Capillary Growth in Human Skeletal Muscle and the Dynamics of VEGF. Microcirculation 2014, 21, 301–314. [Google Scholar] [CrossRef] [PubMed]
- Meulenbeld, A.; Ramondt, S.; Sweegers, M.G.; Quee, F.A.; Prinsze, F.J.; Hoogendijk, E.O.; Swinkels, D.W.; van den Hurk, K. Effectiveness of Ferritin-Guided Donation Intervals in Whole-Blood Donors in the Netherlands (FIND'EM): A Stepped-Wedge Cluster-Randomised Trial. Lancet 2024, 404, 31–43. [Google Scholar] [CrossRef] [PubMed]
- Spekman, M.L.C.; Ramondt, S.; Sweegers, M.G. Whole Blood Donor Behavior and Availability After Deferral: Consequences of a New Ferritin Monitoring Policy. Transfusion 2021, 61, 1112–1121. [Google Scholar] [CrossRef] [PubMed]
- Infanti, L. Protecting the Blood Donor: Ferritin-Based Intervals to Improve Donor Health. Lancet 2024, 404, 2–3. [Google Scholar] [CrossRef] [PubMed]
- Peake, J.M.; Suzuki, K.; Coombes, J.S. The Influence of Antioxidant Supplementation on Markers of Inflammation and the Relationship to Oxidative Stress After Exercise. J. Nutr. Biochem. 2007, 18, 357–371. [Google Scholar] [CrossRef] [PubMed]
- Semenza, G.L. Hypoxia-Inducible Factor 1: Oxygen Homeostasis and Disease Pathophysiology. Trends Mol. Med. 2001, 7, 345–350. [Google Scholar] [CrossRef] [PubMed]
- Semenza, G.L. HIF-1 and Mechanisms of Hypoxia Sensing. Curr. Opin. Cell Biol. 2001, 13, 167–171. [Google Scholar] [CrossRef] [PubMed]
- Wenger, R.H. Cellular Adaptation to Hypoxia: O₂-Sensing Protein Hydroxylases, Hypoxia-Inducible Transcription Factors, and O₂-Regulated Gene Expression. FASEB J. 2002, 16, 1151–1162. [Google Scholar] [CrossRef] [PubMed]
- Maxwell, P.H.; Ratcliffe, P.J. Oxygen Sensors and Angiogenesis. Semin. Cell Dev. Biol. 2002, 13, 29–37. [Google Scholar] [CrossRef] [PubMed]
- Iyer, N.V.; Kotch, L.E.; Agani, F.; Leung, S.W.; Laughner, E.; Wenger, R.H.; Gassmann, M.; Gearhart, J.D.; Lawler, A.M.; Yu, A.Y.; et al. Cellular and Developmental Control of O₂ Homeostasis by Hypoxia-Inducible Factor 1 Alpha. Genes Dev. 1998, 12, 149–162. [Google Scholar] [CrossRef] [PubMed]
- Pugh, C.W. Modulation of the Hypoxic Response. Adv. Exp. Med. Biol. 2016, 903, 259–271. [Google Scholar] [CrossRef] [PubMed]
- Lando, D.; Peet, D.J.; Whelan, D.A.; Gorman, J.J.; Whitelaw, M.L. Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch. Science 2002, 295, 858–861. [Google Scholar] [CrossRef] [PubMed]

| Characteristic | Study group (N=159) | Control group (N=165) | Total (N=324) |
|---|---|---|---|
| Age (median, range) | 45 (22–68) | 37 (18–62) | 40 (18–68) |
| Sex (M/F) | 146 / 13 | 116 / 49 | 262 / 62 |
| p value | — | — | Age: <0.001; Sex: <0.001 |
| Level of education | Study group N (%) | Control group N (%) | Total N (%) | Difference between study and control groups (p) |
|---|---|---|---|---|
| Primary school | 3 (1.9) | 3 (1.8) | 6 (2.0) | 0.993 |
| High school | 109 (68.6) | 93 (56.4) | 202 (62.3) | 0.074 |
| College | 15 (9.4) | 18 (10.9) | 33 (10.2) | 0.889 |
| University | 32 (20.1) | 51 (30.9) | 83 (25.6) | 0.282 |
| p (Difference between level of education) | <0.001 | <0.001 | <0.001 | |
| Total | 159 (100) | 165 (100) | 324 (100) |
| Employment status |
Study group N (%) |
Control group N (%) |
Total N (%) |
Difference between study and control groups (p) |
|---|---|---|---|---|
| Employed | 138 (86.8) | 135 (81.8) | 273 (84.3) | 0.257 |
| Unemployed | 2 (1.3) | 8 (4.8) | 10 (3.1) | 0.832 |
| High school or university student | 1 (0.6) | 20 (12.1) | 21 (6.5) | 0.732 |
| Retired | 18 (11.3) | 2 (1.2) | 20 (6,2) | 0.664 |
| p | <0.001 | <0.001 | <0.001 | |
| Total | 159 (100) | 165 (100) | 324 (100) |
| Marital status | Study group N (%) | Control group N (%) | Total N (%) |
Difference between study and control groups, p |
|---|---|---|---|---|
| Single | 29 (18.2) | 52 (31.5) | 81 (25) | 0.198 |
| Married | 96 (60.4) | 62 (37.6) | 158 (48.8) | 0.0053 |
| In a common-law union | 22 (13.8) | 41 (24.8) | 63 (19.4) | 0.310 |
| Divorced | 10 (6.3) | 9 (5.5) | 19 (5.9) | 0.942 |
| Widowed | 2 (1.3) | 1 (0.6) | 3 (0.9) | 0.964 |
| p | <0.001 | <0.001 | <0.001 | |
| Total | 159 (100) | 165 (100) | 324 (100) |
| Characteristic | Study group N (%) | Control group N (%) | Difference between study and control groups p |
|---|---|---|---|
| Total number of donations (median, IQR) | 37 (23–61) | 7 (4–13) | <0.001 |
| Age at first donation (median, IQR) | 20 (18–24) | 23 (19–35) | <0.001 |
| Deferred donors | Study group N (%) | Control group N (%) | Total N (%) | Difference between study and control groups p |
|---|---|---|---|---|
| YES | 82 (51.6) | 78 (48.4) | 159 (49.4) | 0,439 |
| NO | 77 (46.7) | 87 (52.3) | 165 (50.9) | |
| Total | 159 (100) | 165 (100) | 324 (100) |
| Reasons for deferral | N | % |
|---|---|---|
| Blood pressure | 12 | 7.5% |
| Low hemoglobin | 87 | 54.4% |
| Blood pressure and low hemoglobin | 13 | 8.1% |
| Acupuncture as pain therapy | 1 | 0.6% |
| Illness | 1 | 0.6% |
| COVID-19 | 1 | 0.6% |
| Facial dermatitis | 1 | 0.6% |
| Endoscopy within 4 months | 1 | 0.6% |
| Fracture | 1 | 0.6% |
| Herpes | 4 | 2.5% |
| Colonoscopy | 2 | 1.3% |
| Use of antibiotics | 1 | 0.6% |
| False-positive markers | 1 | 0.6% |
| Hantavirus fever | 1 | 0.6% |
| Mononucleosis | 2 | 1.3% |
| Recent surgery | 1 | 0.6% |
| Deferred donors (N = 160); Sex |
Study group N (%) |
Control group N (%) | Total N (%) | Difference between study and control groups p |
|---|---|---|---|---|
| Men N=262 | 74 (90) | 46 (59) | 120 (75) | <0.001 |
| Women N=62 | 8 (10) | 32 (41) | 40 (25) | 0.104 |
| p | <0.001 | 0,120 | <0.001 | |
| Total | 82 (100) | 78 (100) | 160 (100) |
| Food item | Study group (N=159) | Control group (N=165) | Total (N=324) | p |
|---|---|---|---|---|
| Red meat | 4 (3–4) | 4 (3–4) | 4 (3–4) | >0.05 |
| White meat | 4 (3–4) | 4 (3–4) | 4 (3–4) | >0.05 |
| Processed meat products | 4 (3–4) | 4 (3–4) | 4 (3–4) | >0.05 |
| Eggs | 4 (3–4) | 4 (3–4) | 4 (3–4) | >0.05 |
| Oily fish | 2 (2–3) | 2 (2–3) | 2 (2–3) | >0.05 |
| White fish | 2 (2–3) | 2 (1.75–3) | 2 (2–3) | >0.05 |
| Milk | 4 (3–6) | 3 (3–6) | 4 (3–6) | >0.05 |
| Yogurt/kefir | 4 (3–4) | 4 (3–4) | 4 (3–4) | >0.05 |
| Cheese | 4 (3–4) | 4 (3–5) | 4 (3–4) | >0.05 |
| Butter | 3 (2–3) | 3 (2–4) | 3 (2–4) | >0.05 |
| Cream | 2 (1–3) | 2 (1–3) | 2 (1–3) | >0.05 |
| Green leafy vegetables | 4 (3–4) | 4 (3–5) | 4 (3–4,5) | >0.05 |
| Other vegetables | 4 (3–4) | 4 (3–4) | 4 (3–4) | >0.05 |
| Potato/sweet potato | 4 (4–5) | 4 (4) | 4 (4–5) | >0.05 |
| Root vegetables | 4 (3–4) | 4 (3–4) | 4 (3–4) | >0.05 |
| Fruit | 4 (4–5) | 4 (3–5) | 4 (3–5) | >0.05 |
| Citrus fruit | 4 (3–4) | 4 (3–5) | 4 (3–5) | >0.05 |
| Berries | 2 (2–3) | 3 (2–4) | 2.5 (2–4) | 0.025 |
| Nuts | 3 (2–4) | 3 (2–4) | 3 (2–4) | >0.05 |
| Avocado | 1 (1) | 1 (1) | 1 (1) | >0.05 |
| Legumes | 3 (2–4) | 3 (2–4) | 3 (2–4) | >0.05 |
| Cereals | 3 (2–4) | 3 (2–4) | 3 (2–4) | >0.05 |
| Parameter | Before donation | After donation | Change |
|---|---|---|---|
| Average HIF-1α serum concentration (pg/mL) | 1.0 ±0.2 | 1.8±0.3 | +80% |
| Range | 0.7-1.3 | 1.4-2.3 | - |
| Parameter | Folic acid (pg/mL) | Vitamin B12 (pg/mL) |
|---|---|---|
| N | 311 | 311 |
| Minimum | 225.7 | 8.9 |
| Maximum | 15169.5 | 820.3 |
| Mean | 4630.1 | 141.2 |
| Median | 2578.1 | 132.0 |
| SD | 3681.4 | 61.6 |
| 25–75 P | 1558.3 – 7552.1 | 105.7 – 164.3 |
| Normal distribution | <0.0001 | <0.0001 |
| Parameter: Folate (pg/mL) | Study group | Control group |
|---|---|---|
| N | 152 | 159 |
| Minimum | 421.4 | 225.7 |
| Maximum | 13694.9 | 15169.5 |
| Median | 2287.6 | 4453.1 |
| SD | 3557.5137 | 3786.3191 |
| 95% CI for the median | 2040.1 – 4812.3 | 2320.2 – 5958.1 |
| Interquartile range | 1468.9 – 7182.7 | 1721.4 – 7732.4 |
| Parameter: vitamin B12 (pg/mL) | Study group | Control group |
|---|---|---|
| N | 155 | 156 |
| Minimum | 8.9 | 26.7 |
| Maximum | 341.2 | 820.3 |
| Median | 132.2 | 131.8 |
| 95% CI for the median | 126.8 – 141.0 | 126.9 – 140.8 |
| Interquartile range | 106.1 – 166.4 | 105.3 – 160.6 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).